PubRank

Gregory J Kato

Author PubWeight™ 112.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005 6.14
2 Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol 2007 2.76
3 A network model to predict the risk of death in sickle cell disease. Blood 2007 2.39
4 Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007 2.31
5 An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med 2014 2.23
6 Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica 2009 2.20
7 N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006 2.04
8 Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation 2011 2.01
9 Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 2008 1.75
10 The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica 2012 1.72
11 Mortality in adults with sickle cell disease and pulmonary hypertension. JAMA 2012 1.72
12 Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood 2011 1.64
13 A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease. Am J Respir Crit Care Med 2012 1.63
14 Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol 2005 1.47
15 Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 2011 1.38
16 Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program 2005 1.36
17 Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci 2005 1.35
18 Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol 2006 1.34
19 Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol 2008 1.34
20 Increased pulmonary pressures and myocardial wall stress in children with severe malaria. J Infect Dis 2010 1.33
21 A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease. BMC Med Genomics 2012 1.29
22 Pulmonary hypertension and NO in sickle cell. Blood 2010 1.28
23 High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension. Blood 2010 1.22
24 Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am J Cardiol 2009 1.22
25 Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea. Am J Hematol 2009 1.20
26 Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood 2008 1.18
27 Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood 2009 1.16
28 Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica 2010 1.16
29 Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management. Am J Hematol 2008 1.16
30 Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer 2008 1.16
31 Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med 2013 1.16
32 Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. Am J Hematol 2008 1.15
33 Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol 2010 1.13
34 Sickle cell disease and nitric oxide: a paradigm shift? Int J Biochem Cell Biol 2006 1.13
35 Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 2012 1.12
36 Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients. Br J Haematol 2009 1.12
37 Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates. Am J Hematol 2012 1.10
38 Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications. Am J Hematol 2012 1.10
39 Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med 2008 1.07
40 Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One 2009 1.07
41 Reconstruction of Thermographic Signals to Map Perforator Vessels in Humans. Quant Infrared Thermogr J 2012 1.07
42 Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease. Am J Hematol 2014 1.07
43 Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease. Microvasc Res 2012 1.06
44 Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr 2011 1.05
45 Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis. Arterioscler Thromb Vasc Biol 2013 1.04
46 Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression. J Clin Invest 2014 1.03
47 Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Proc Am Thorac Soc 2009 1.03
48 Current therapy of sickle cell disease. Haematologica 2006 1.03
49 Identification and characterization of the novel centrosome-associated protein CCCAP. Gene 2003 1.03
50 Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease. Br J Haematol 2009 1.03
51 Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I/II study. Br J Haematol 2008 1.03
52 Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1/CIP1) proteins in human acute lymphoblastic leukemia cells. Blood 2002 0.99
53 Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. Haematologica 2006 0.99
54 Ancestry of African Americans with sickle cell disease. Blood Cells Mol Dis 2011 0.96
55 Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One 2013 0.96
56 Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia. Br J Haematol 2008 0.96
57 NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease. Br J Haematol 2011 0.96
58 Sleep disturbance, depression and pain in adults with sickle cell disease. BMC Psychiatry 2014 0.94
59 Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia). Haematologica 2011 0.94
60 Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease. Haematologica 2010 0.90
61 Genetic determinants of haemolysis in sickle cell anaemia. Br J Haematol 2013 0.89
62 NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa. Br J Haematol 2010 0.89
63 Leg ulcers in sickle cell disease: current patterns and practices. Hemoglobin 2013 0.89
64 Laboratory and echocardiography markers in sickle cell patients with leg ulcers. Am J Hematol 2011 0.89
65 Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. Antioxid Redox Signal 2010 0.88
66 Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia. Haematologica 2012 0.88
67 Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens! Haematologica 2008 0.87
68 Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 2014 0.86
69 Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia. Br J Haematol 2010 0.86
70 Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function. Obesity (Silver Spring) 2012 0.85
71 Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease. Eur J Haematol 2013 0.84
72 Expression of regulatory platelet microRNAs in patients with sickle cell disease. PLoS One 2013 0.84
73 High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women. Am J Cardiol 2011 0.82
74 Circulating endothelial progenitor cells in adults with sickle cell disease. Pulm Circ 2013 0.81
75 Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease. Blood 2012 0.81
76 Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease. Haematologica 2013 0.81
77 A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia. Am J Hematol 2014 0.81
78 The proteome of sickle cell disease: insights from exploratory proteomic profiling. Expert Rev Proteomics 2010 0.81
79 Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin. Haematologica 2012 0.79
80 Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes. Hemoglobin 2010 0.79
81 Predictors of osteoclast activity in patients with sickle cell disease. Haematologica 2011 0.79
82 Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia. Am J Hematol 2013 0.79
83 Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 2017 0.78
84 Characterizing non-linear dependencies among pairs of clinical variables and imaging data. Conf Proc IEEE Eng Med Biol Soc 2012 0.78
85 TRV: a physiological biomarker in sickle cell disease. Pediatr Blood Cancer 2011 0.78
86 A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution. Clin J Pain 2014 0.78
87 Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia. Br J Haematol 2011 0.78
88 Imaging flow cytometry for morphologic and phenotypic characterization of rare circulating endothelial cells. Cytometry B Clin Cytom 2013 0.78
89 Severe pulmonary hypertension in an adolescent with sickle cell disease. Am J Hematol 2008 0.77
90 Understanding the erythrocyte storage lesion. Anesthesiology 2012 0.77
91 Liver stiffness increases acutely during sickle cell vaso-occlusive crisis. Am J Hematol 2013 0.77
92 Vascular complications after splenectomy for hematologic disorders. Blood 2009 0.77
93 A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase. Anal Biochem 2013 0.76
94 Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide. Br J Haematol 2014 0.76
95 Lactate dehydrogenase and hemolysis in sickle cell disease. Blood 2013 0.76
96 Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Pediatr Pulmonol 2009 0.76
97 Reply: Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoption. Am J Respir Crit Care Med 2014 0.75
98 Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels. Am J Cardiol 2013 0.75